Study to Infuse Haploidentical Natural Killer Cells in Patients With Relapsed or Refractory Neuroblastoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cell therapies; Cyclophosphamide; Fludarabine; Interleukin-2
- Indications Neuroblastoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 24 Sep 2020 Biomarkers information updated
- 02 Jul 2012 Actual patient number is 1 according to ClinicalTrials.gov.
- 02 Jul 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.